focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,485.00
Bid: 3,455.00
Ask: 3,465.00
Change: 20.00 (0.58%)
Spread: 10.00 (0.289%)
Open: 3,475.00
High: 3,490.00
Low: 3,445.00
Prev. Close: 3,465.00
CLDN Live PriceLast checked at -
Caledonia is an Investment Trust

To grow net assets and dividends over the long term, whilst managing risk to avoid permanent loss of capital.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

27 Nov 2023 16:37

RNS Number : 6533U
Caledonia Investments PLC
27 November 2023

Caledonia Investments plc

Notification of transactions of persons discharging managerial responsibilities ("PDMR") or persons closely associated with them ("PCA")

Pursuant to the requirements of the Market Abuse Regulation, Caledonia Investments plc ("Caledonia" or the "Company") announces that on 24 November 2023 nil-cost options over 17,573 ordinary 5p shares ("Shares") in Caledonia were granted to one of its directors, Rob Memmott, under the Caledonia Investments 2020 Performance Share Scheme (the "PSS"). The Company's share price used to determine the number of Shares subject to the PSS award was 3585p.

Subject to the rules of the PSS, nil-cost options are exercisable between three and ten years after the date of grant. Performance is measured over three years for one-third of the PSS awards which are subject to a post-vesting holding period, on an after-tax basis, of two years. The remaining two-thirds of the awards are subject to performance over five years.

The total number of Shares held under option by Mr Memmott under the PSS following this nil-cost option grant is 17,573.

Further information required by the Market Abuse Regulation in relation to these transactions is set out in the appendix below.

Enquiries:

Richard Webster

Company Secretary

Tel: + 44 20 7802 8080

27 November 2023

APPENDIX

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Robert William Memmott

2

Reason for the notification

a)

Position/status

Director/Chief Financial Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Caledonia Investments plc

b)

LEI

2138002FX1MYCA5ZZH32

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary 5p shares

GB0001639920

b)

Nature of the transaction

Grant of nil-cost options over ordinary 5p shares under the Caledonia Investments 2020 Performance Share Scheme ("PSS")

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.00

17,573

d)

Aggregated information

- Aggregated volume

- Price

17,573

Nil

e)

Date of the transaction

24 November 2023

f)

Place of the transaction

Outside a trading venue

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBLBDBRXDDGXR
Date   Source Headline
6th Mar 20232:18 pmRNSNet Asset Value(s)
6th Feb 202311:47 amRNSNet Asset Value(s)
9th Jan 20237:00 amRNSUnaudited net asset value and portfolio update
7th Dec 20229:22 amRNSNet Asset Value(s)
22nd Nov 20227:00 amRNSDirectorate Change
22nd Nov 20227:00 amRNSHalf-year Report
7th Nov 202210:49 amRNSNet Asset Value(s)
7th Oct 20227:00 amRNSUnaudited net asset value and portfolio update
30th Sep 20224:21 pmRNSDirector/PDMR Shareholding
23rd Sep 20222:51 pmRNSDirector/PDMR Shareholding
6th Sep 202210:17 amRNSNet Asset Value(s)
23rd Aug 20225:21 pmRNSDirector/PDMR Shareholding
15th Aug 20222:21 pmRNSDirector Declaration
4th Aug 202212:41 pmRNSNet Asset Value(s)
27th Jul 20224:47 pmRNSResult of AGM
19th Jul 20224:59 pmRNSDirector Declaration
7th Jul 20227:00 amRNSUnaudited net asset value and portfolio update
23rd Jun 20224:00 pmRNSAnnual Financial Report
20th Jun 202212:20 pmRNSDirector/PDMR Shareholding
20th Jun 202212:20 pmRNSDirector/PDMR Shareholding
16th Jun 20224:32 pmRNSDirector/PDMR Shareholding
14th Jun 20221:51 pmRNSDirector/PDMR Shareholding
8th Jun 20229:36 amRNSNet Asset Value(s)
6th Jun 20223:33 pmRNSDirector/PDMR Shareholding
31st May 20224:50 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSFinal Results
6th May 20229:02 amRNSNet Asset Value(s)
7th Apr 20227:00 amRNSUnaudited net asset value and portfolio update
4th Apr 202210:10 amRNSDirectorate Change
25th Mar 20224:47 pmRNSDirector/PDMR Shareholding
21st Mar 20223:56 pmRNSDirector/PDMR Shareholding
16th Mar 20222:05 pmRNSDirector/PDMR Shareholding
7th Mar 20227:00 amRNSDirectorate Change
7th Mar 20227:00 amRNSNet Asset Value(s)
28th Feb 20224:59 pmRNSTotal Voting Rights
4th Feb 20224:56 pmRNSTransaction in Own Shares
4th Feb 20229:52 amRNSNet Asset Value(s)
31st Jan 20225:23 pmRNSTotal Voting Rights
28th Jan 20225:25 pmRNSTransaction in Own Shares
7th Jan 202211:40 amRNSUnaudited net asset value and portfolio update
4th Jan 20227:00 amRNSTotal Voting Rights
21st Dec 20214:44 pmRNSDisposal
20th Dec 202110:00 amRNSDirector Declaration
17th Dec 20215:32 pmRNSTransaction in Own Shares
10th Dec 20215:16 pmRNSTransaction in Own Shares
7th Dec 20219:59 amRNSNet Asset Value(s)
30th Nov 20215:30 pmRNSTotal Voting Rights
26th Nov 20214:49 pmRNSTransaction in Own Shares
23rd Nov 20217:00 amRNSBoard Changes
23rd Nov 20217:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.